What we know so far
| Offer price: | $0.20 |
| Proposed code: | LTP |
| Expected raise: | $6,000,000 – $7,000,000 |
| Expected listing: | 11 December 2023 |
Finder makes money from featured partners, but editorial opinions are our own.
LTR Pharma shares are now publicly available to purchase on the Australian Securities Exchange (ASX). Here's what we know about the IPO and how you can buy in.
Where to invest in the LTR Pharma IPO
LTR Pharma has listed on the ASX, so you can now buy shares over the stock market. To do that, you'll need to be signed up to a broker. Your cheapest option is to sign up to an online broker. Check out the steps below:
How to buy shares when LTR Pharma lists
- Compare share trading platforms. To buy shares in an Australian-listed company, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for LTR Pharma. Find the share by name or ticker symbol: LTP. You can also search for any other shares traded publicly on exchanges available within your chosen platform.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until LTR Pharma reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At price of at you're buying the shares, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of LTR Pharma. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
Our top pick for
Best for day trading
Our top pick for
Education & learning
Our top pick for
Low commission
What we know about the LTR Pharma IPO
LTR Pharma lodged its prospectus with the Australian Securities and Investments Commission (ASIC) to list on the ASX under the ticker symbol LTP.
Alpine Capital Pty Ltd were appointed as lead managers with an expected raise of $6,000,000 – $7,000,000 at $0.20 per share. You can check out some of the key dates and figures in the table below:
| LTR Pharma IPO key numbers | |
|---|---|
| Offer price | $0.20 |
| Dividend yield | 0% |
| Total number of shares available under the offer | 30,000,000 – 35,000,000 |
| Proposed ASX code | ASX: LTP |
| Target market cap | $26,884,050.40 – $27,884,050.40 |
| Retail offer opens | 10 November 2023 |
| Retail offer closes | 24 November 2023 |
| Expected listing on ASX | 11 December 2023 |
| Expected dispatch of holding statements | 4 December 2023 |
According to latest information available, retail investors (regular investors) have between 10 November 2023 and 24 November 2023 to participate in the LTR Pharma IPO. After the retail offer close date, you'll need to wait until the stock is publicly available on the ASX to buy shares.
Where to buy LTR Pharma shares
The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
1 - 5 of 31
Balance sheet
In 2023, the company generated $90 of revenue. Estimated net profit (NPAT) in 2023 was ($1,454,905), and ($1,027,121) in the prior year.Company history
LTR Pharma launched in 2020 and is head quartered in Queensland, Australia
How do I buy shares?
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades. Read the Product Disclosure Statement (PDS) and Target Market Determination (TMD) for the product on the provider's website.
More resources on Finder
More guides on Finder
-
Australia’s top investment funds vs ChatGPT and Bard
We put Australia's top funds to the test against ChatGPT and Google's Bard to see which stock portfolio's were the best performing.
-
Best performing stocks on the ASX in 2024 (Updated weekly)
Looking for the best performing stocks in Australia? We update this list weekly.
-
The best ASX shares to buy now in 2024? (September update)
Here are our algorithm-selected 20 Aussie stocks worth watching in 2024.
-
The best AI stocks in the US and Australia in 2024
Here's what investors should know before adding AI stocks to their portfolios.
-
How to invest in the S&P 500
Find out the different ways you can invest in the S&P 500 index from Australia.
-
Saxo Invested Australia review: Share trading platform
Saxo Invested allows you to trade over 60,000 instruments on 50 global stock exchanges and provides lower commissions for active traders.
-
The cheapest stock brokers in Australia (Sep 2024)
Find cheap stock brokerage in Australia when buying and selling shares on the ASX and other international exchanges.
-
Best investment and stock trading apps in Australia (2024)
Compare share trading apps to find out which app has all the tools and resources you need to reach your investment goals.
-
What are dividends?
A dividend is the distribution of some of a company's profits that are paid regularly to its shareholders.
-
14 best share trading platforms Australia – ranked
Follow these tips to find the best share trading platform for you.
Ask a question